Fetal akinesia deformation sequence (FADS) is a broad spectrum disorder with absent fetal movements as the unifying feature. The etiology of FADS is heterogeneous and mostly still unknown. A prenatal diagnosis of FADS relies on clinical features obtained by ultrasound and fetal muscle pathology. However, the recent advances of next-generation sequencing (NGS) can effectively provide a definitive molecular diagnosis.
INTRODUCTION
Moessinger proposed that decreased or absent fetal movements, independent of the cause, can lead to a predictable series of secondary anomalies [1] . Clinical symptoms of fetal akinesia deformation sequence (FADS) include joint contractures, subcutaneous edema, fetal hydrops, polyhydramnios, pulmonary hypoplasia, intrauterine growth restriction, micrognathia, cleft palate, hypoplasia of the limb muscles, short umbilical cord, decreased intestinal motility, and shortened bowel, with a phenotype that may be complicated by brain anomalies or restrictive dermopathy. The etiology of FADS is heterogeneous: Both genetic and environmental factors may affect normal developmental processes in the fetus and lead to FADS [2] . Mutations in genes expressed at the neuromuscular junction (NMJ) are increasingly recognized as important causes of FADS [3] . MUSK is required for the formation and maintenance of the NMJ. To date, two homozygous mutations of MUSK have been reported to cause FASD: a c.40dupA mutation [4] and a missense variant [c.1724T4C; p. (Ile575Thr)] [5] . Here we describe a compound heterozygous mutation of the MUSK gene that caused FADS in a fetus in China and possibly in her sibling.
CASE PRESENTATION

Chief complaints
Menopause for 6 mo and fetal abnormality for 13 d.
History of present illness
A 34-year-old woman, gravida 2, para 0, abortus 1, was referred to our department because of fetal abnormality. She had regular menstrual cycle before pregnancy, the last menstrual period was February 27, 2017, and the expected date of childbirth was December 3, 2017. She went to prenatal examination regularly, the noninvasive prenatal test result was low risk, the prenatal ultrasound examination showed abnormal ultrasonographic signs and lack of fetal movement. The mother had not felt any fetal movement during pregnancy. The parents decided to terminate the second pregnancy at the gestational age of 24 wk and 3 d of gestation.
History of past illness
A previous pregnancy showed a similarly affected fetus electively aborted at 25 wk of gestation. However, only ultrasound information about the fetus was available with no postnatal findings (case 1 in Table 1 ).
Personal and family history
The parents were non-consanguineous Chinese, and there was no family history of the parents. 
Fetal stomach not visualized [4] .
Pedigree 3: The 11 fetuses diagnosed with a c.1724T > C mutation reported by Tan-Sindhunata et al [5] . F: Female; M: Male; GW: Gestational week; NA: Not assessed; FGR: Fetal growth restriction; TOP: Termination of pregnancy; IUFD: Intrauterine fetal death.
Physical examination upon admission
General physical examination was normal. Fatal heart rate was 146 bpm, the height of the uterine fundus was 24 cm, and there was fetal head presentation.
Laboratory examinations
The results of routine blood test were: WBC 1.1 × 10 10 /L, NE 71.0%, RBC 3.56 × 10 12 /L, HGB 115 g/L, and PLT 2.79 × 10 11 /L. K + was 3.99 mmol/L, Na + was 136.3 mmol/L, and Ca 2+ was 2.32 mmol/L. Routine urine test was normal. Total genomic DNA was extracted from the aborted fetus' muscular tissue and peripheral blood leukocytes were isolated from the parents according to standard protocols. Targeted enrichment of whole exome DNA was performed using a Nextera Rapid Capture Exome kit (Illumina, San Diego, CA, United States) according to manufacturers' protocols. Whole exome libraries were then sequenced on an Illumina HiSeq platform using a 2×100 bp sequencing protocol. Potentially homozygous, compound heterozygous, and de novo variants were filtered out. An identified compound heterozygous mutation in the MUSK gene was confirmed using standard Sanger sequencing. For amplification of the genomic region that includes the mutations identified in this study, the following two primer pairs were used: (1) GTGGTCGGGATTGACAGCA (forward) and CACAGCTGAAGACCCTGGG (reverse); and (2) CCCAGGGTCTTCAGCTGTG (forward) and CCTCTGTCATGCTGCCCAA (reverse). We found that the fetus carried both a frameshift mutation, c.421delC (p. Pro141Hisfs*15), and a missense mutation, c.220C > T (p. R74W) in the MUSK gene, involving the same transcript (ENST00000374448.8; Figure 1D ). After examining the mutation sites of family members, it was determined that fetal mutations were inherited from both parents. The fetus' mother carried the c.220C > T mutation and the c.421delC mutation was detected in the fetus' father; thus the fetus received two different MUSK mutations, one from each parent, resulting in a compound heterozygous mutation.
Hematoxylin and eosin staining and immunohistochemical staining were performed on muscle biopsies from the affected fetus, and a dead fetus after spontaneous abortion at the same gestational weeks. Immunohistochemical analysis was performed using mouse monoclonal antibodies against slow myosin heavy chain (NCL MHCs; 1:500 dilution), and fast myosin heavy chain (MHCf; 1:500 dilution), both of them were purchased from Abcam (Cambridge, United Kingdom). Significant atrophy was demonstrated in all muscle biopsies. Only a few scattered fibers that were analysed expressed slow myosin. The vast majority of fibers expressed fast myosin. Increased amounts of loose connective tissue were found around and within muscle fascicles. A comparison of MHCf in samples from normal and affected fetuses showed a statistically significant difference between the two, with the affected fetus showing more MHCf (Figure 2 ).
Imaging examinations
Prenatal ultrasound signs for the second female fetus included pronated club hands ( Figure 1B and C) and rocker-bottom feet. In addition, a micromandible, increased nuchal skin thickness (1.05 cm), and fetal hydrops were also noted. Fetal growth was not appropriate for the gestational age and fetal growth restriction was diagnosed. A clinical diagnosis of FADS was made (case 2 in Table 1 ).
FINAL DIAGNOSIS
FADS syndrome; G1 P0 G24 wk, delivery of a dead fetus.
TREATMENT
We inducted the labor after routine examinations and consultation of relevant experts.
OUTCOME AND FOLLOW-UP
The patient was discharged on the third day after abortion and was followed for preimplantation genetic diagnosis (PGD).
DISCUSSION
The unifying feature of FADS is a reduction or lack of fetal movement. The clinical symptoms of the two affected fetuses above and two reviews of several affected fetuses described in the medical literature, including prenatal and postnatal findings, are summarized in Table 1 . Nearly all cases with an affected fetus chose to terminate the pregnancy in the face of reduced/absent fetal movements and joint contractures. Eight neonates died within a few hours or days after birth and none survived during the neonatal period. Six fetuses did not undergo a prenatal assessment and died within a few hours after birth. In this regard, a prenatal examination is always important if FADS is suspected.
Although etiologies are heterogeneous, the prevailing view is that more than half of all FADS cases are of neuromuscular origin. Several causative gene mutations have been identified because of the development of NGS technologies. Gene mutations of proteins at the NMJ are presently recognized as an important cause of FADS, including CHRNA1 (OMIM 100690) [6] , CHRND (OMIM 100720) [6] , CHRNG (OMIM 100730) [7] , DOK7 (OMIM 610285) [8] , RAPSN (OMIM 601592) [9] , and MUSK (OMIM601296) [4] . Up to December 31, 2017, MUSK mutations have been identified in three families with FADS involving 18 patients, including the present case ( Table 1) . The four mutations in the three pedigrees are located in exons ( Figure 1G ). The MUSK protein is highly conserved among different species ( Figure 1F) , and hence the fulllength protein is important for its function. In this case, the c.421delC frameshift A: Tissues from the affected fetus; A i: Hematoxylin and eosin staining showed a large variation in muscle fiber size, with many atrophic fibers and increased amounts of loose connective tissue; A ii: Immunohistochemistry with antibody against slow myosin demonstrated only a few scattered type 1 fibers; A iii: Immunohistochemistry with antibody against fast myosin demonstrated that the majority were muscle fibers; B: The results for a control fetus (dead fetus after a spontaneous abortion after the same number of gestational weeks); C: Western blot indicating that the amount of fast myosin heavy chain was significantly higher in the muscles of the affected fetus compared to the control fetus. The loading control is GAPDH. P < 0.05. mutation led to the premature termination of MUSK protein translation and the generation of a truncated, 154-amino acid protein, which resulted in MUSK loss of function. A c.220C > T missense mutation caused an amino acid substitution at residue 74 from arginine to tryptophan. This site is also highly conserved among different species ( Figure 1E) .
MUSK is required for the formation and maintenance of the NMJ. The MUSK protein contains three Ig-like domains: A frizzled-like cysteine-rich domain, a transmembrane helix, and a cytoplasmic tyrosine kinase domain [10] (Figure 1G ). In this case, c.421delC and c.220C > T mutations are located in Ig-like 1/2 domains, which are important for the agrin activation of MUSK. Histological and immunohistochemical findings revealed fiber atrophy and a predominance of type II fibers. We proposed that the compound heterozygous mutation caused a loss of the normal function of MUSK.
CONCLUSION
In conclusion, we herein have reported the first Chinese case of a compound heterozygous mutation of MUSK that caused FADS as an important addition to the MUSK gene mutation database. Further investigation of the relationship between the phenotype and genotype of the compound heterozygous mutation will enable a better understanding of this rare disease.
